Olema Pharmaceuticals, Inc. (OLMA)
15.12
-0.01
(-0.07%)
USD |
NASDAQ |
May 08, 10:42
Olema Pharmaceuticals Research and Development Expense (Annual) : 157.70M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| EyePoint, Inc. | 221.04M |
| CytomX Therapeutics, Inc. | 65.80M |
| Protagonist Therapeutics, Inc. | 159.29M |
| Disc Medicine, Inc. | 170.36M |
| Nuvalent, Inc. | 306.97M |